Related references
Note: Only part of the references are listed.Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers
Christine Koch et al.
CANCERS (2021)
The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis
Zhoujing Cheng et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
Kai-Cai Liu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
Masatoshi Kudo et al.
GUT (2020)
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations
Ashish Kumar et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2020)
Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study
Shih-Chieh Chien et al.
LIVER CANCER (2019)
Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers
Lucia Cerrito et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Hepatocellular Carcinoma: Etiology and Current and Future Drugs
Aastha Jindal et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice
Edoardo Giovanni Giannini et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Staging systems of hepatocellular carcinoma: A review
Sreeshma Tellapuri et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2018)
Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis
XiuPing Zhang et al.
ONCOTARGET (2017)
Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience
Dominik Bettinger et al.
BMC GASTROENTEROLOGY (2017)
Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis
Jian-Jun Leng et al.
ANZ JOURNAL OF SURGERY (2016)
GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis
R. Lencioni et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients
Y. Zhao et al.
ANNALS OF ONCOLOGY (2013)
Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review
Yan Zhao et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2013)
Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis
Tong-Chun Xue et al.
BMC GASTROENTEROLOGY (2013)
The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma
Xu-Dong Qu et al.
BMC CANCER (2012)
Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib
Matthias Pinter et al.
RADIOLOGY (2012)
Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: Does transarterial chemoembolization improve survival in these patients?
Dong-Jun Yoo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization
B. Wang et al.
ACTA RADIOLOGICA (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma
Kiminori Uka et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Share Paper
